Abstract
Serological typing of P. aeruginosa is the most simple and reliable procedure recommended for ≪ in-house ≫ investigations and for studies of suspected outbreaks of infection by this microorganism. It is also a useful procedure in order to know serotype prevalence in a definite geografical area and to obtain indications about the more appropriate composition of polivalent anti-Pseudomonas vaccines.
In the present report, we describe the relatively high frequency of isolation of serogroup 12 from patients in Palermo, Italy. Serogroup 12 is very rare in north-Europe and in the USA, and, as a consequence, it is not included in some vaccine preparations. In Palermo, strains belonging to this serogroup, resistant to a large number of antibiotics, were on the contrary isolated, during more than six years, in different hospitals and from three out-patients. In a Burns Unit, they were in particular responsible for extensive and life-threatening outbreaks.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
BauerA.W., KirbyW.M., SherrisJ.M. and TurckM. (l966): Antibiotic susceptibility testing by a standardized single disc method. - Am. J. Clin. Pathol. 45: 493–496.
BertiP., MaraniniB. and MazzoniP. (1980): Tipizzazione sierologica di ceppi di Pseudomonas aeruginosa. L Considerazioni cliniche ed epidemiologiche.- Ann. Sclavo 22: 698–708.
BravoE., LettaM.R., AmanteA. and AntonelliM. (1982): Sierotipizzazione di ceppi di P. aeruginosa isolati dall'espettorato di pazienti con fibrosi cistica.- Ann. Sclavo 24: 229–236.
BrokoppC.D., Gomez-LusR. and FarmerJ.J. III (1977): Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens.- J. Clin. Microbiol. 5: 640–649.
ChiaradiaV., CrovattoM., MarchettiG., BasagliaE., SantiniG. and GrattoniE. (1982): Valutazione di alcune caratteristiche biochimiche, sierologiche e di antibiotico-sensibilità di Pseudomonas aeruginosa per fini epidemiologici. - Ann. Sclavo 24: 136–144.
FisherM.W. (1974): Development of immunotherapy due to Pseudomonas aeruginosa. - J. Infect. Dis. 130: S 149–151.
GilliesR.R. and GovanJ.R.W. (1966): Typing of Pseudomonas pyocyanea by pyocine production. -J. Path. Bact. 91: 339–345.
HughR. and GilardiG.L. (1980): Pseudomonas, p. 288–317. In: E.H. Lennette, A. Balows, W.J. Hausler Jr. and J.P. Truant (eds.), Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington, D.C.
LanyiB. and BerganT. (1978): Serological characterization of Pseudomonas aeruginosa, p. 93–168. In: T. Bergan and J.R. Norris (eds.), Methods in Microbiology, vol. 10. Academic Press, London.
LindbergR.B. and LattaR.L. (1974): Phage typing of Pseudomonas aeruginosa: clinical and epidemiological considerations. - J. Infect. Dis. 130: S 33–42.
MaselliM., VitaleR., SinatraA. and GiammancoA. (1981): Endotoxemia evaluation as a guide to diagnosis and prophylaxis in severe burn septic-toxic phases. - Riv. It. Chir. Plast. 13: 55–63.
MikkelsenO.S. (1970): Serotyping of Pseudomonas aeruginosa. 2. Results of an O group classification.- Acta Pathol. Microbiol. Scand. (B) 78: 163–175.
MoodyM.R., YoungV.M., KentonD.M. and VermeulenG.D. (1972): Pseudomonas aeruginosa in a Center for Cancer Research. 1. Distribution of intraspecific types from human and environmental sources. - J. Infect. Dis. 125: 95–101.
Natoli D., Giammanco A., Varvaro P., Teresi S., Menozzi M. and Chiarini A.(1981): Tipizzazione di stipiti di Pseudomonas aeruginosa isolati a Palermo. - Ann. Sclavo 23: 347–355.
PenningtonJ.E. (1979): Immunotherapy of Pseudomonas aeruginosa infection, p. 191–217. In: R.G. Doggett (ed.), Pseudomonas aeruginosa: clinical manifestations of infection and current therapy. Academic Press, New York.
PickettM.J. (1981): Genus Pseudomonas, p. 365–374. In: A.I. Braude, C.E. Davis and J. Fierer (eds.), Medical microbiology and infectious diseases. W.B. Saunders Company, Philadelphia.
PierG.B. and ThomasD.M. (1982): Lipopolysaccharide and high-molecular-weight polysaccharide serotypes of Pseudomonas aeruginosa. - J. Infect. Dis. 145: 217–223.
SachsA. (1970): Active immunoprophylaxis in burns with a new multivalent vaccine. - Lancet ii: 959–961.
Santos-Ferreira M.O. (1977): Marqueurs épidémiologiques de Pseudomonas aeruginosa, leur application à l'étude des infections hospitalières ou Portugal. Thèse Doctorat (Pharmacie), Paris (no. E. 69).
ToucasM., Santos-FerreiraM.O., VieuJ.F. and DelteilM. (1975): Recherches d'anticorps anti-pyocyaniques chez la population normale en France et en Portugal. - Méd. Mal. Inf. 5: 465–468.
VieuJ.F. (1983): Vaccination antipyocyanique. Médecine et Maladies Infectieuses 13: 393–395.
VieuJ.F., VieuM. and Hassan-MassoudB. (1978): Épidémiologie de Pseudomonas aeruginosa en Égypte: étude de 80 couches d'origine hospitalière isolées a Alexandrie. - Bull. Soc. Path. Exotique 71: 48–54.
UllmannU. and SchmullingR.M. (1980): Distribution of Pseudomonas aeruginosa serotypes in bacteriologic specimens and their aminoglycoside resistance. - Zentralbl. Bakteriol. (A) 247: 241–247.
Author information
Authors and Affiliations
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Giammanco, A., Di Stefano, R., Arista, S. et al. Infections caused by Pseudomonas aeruginosa: Relatively frequent isolation of serogroup 12 from clinical specimens. Eur J Epidemiol 1, 104–109 (1985). https://doi.org/10.1007/BF00141801
Issue Date:
DOI: https://doi.org/10.1007/BF00141801